An immunomodulatory photosensitizer-mediated photodynamic therapy synergizes with PD-L1 blockade against metastatic triple-negative breast cancer

The clinical potency of anti-programmed death-ligand 1 (PD-L1) therapy in metastatic triple-negative breast cancer (TNBC) is modest primarily because of the intrinsic low immunogenicity and an immunosuppressive tumor microenvironment (TME). Photodynamic therapy (PDT), an inducer of immunogenic cell...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yuetong Liu, Liming Wang, Feiyan Kong, Tianjun Liu, Hong Liu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2025-07-01
Colección:	Frontiers in Pharmacology
Materias:	photodynamic therapy immunogenic cell death metastatic triple-negative breast cancer programmed death-ligand 1 blockade abscopal effect systemic antitumor immunity
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1651165/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!